The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Three‐dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
Abstract
Cancers are complex and heterogeneous pathological “organs” in a dynamic interplay with their host. Models of human cancer in vitro, used in cancer biology and drug discovery, are generally highly reductionist. These cancer models do not incorporate complexity or heterogeneity. This raises the question as to whether the cancer models' biochemical circuitry (not their genome) represents, with sufficient fidelity, a tumor in situ. Around 95% of new anticancer drugs eventually fail in clinical trial, despite robust indications of activity in existing in vitro pre‐clinical models. Innovative models are required that better capture tumor biology. An important feature of all tissues, and tumors, is that cells grow in three dimensions. Advances in generating and characterizing simple and complex (with added stromal components) three‐dimensional in vitro models (3D models) are reviewed in this article. The application of stirred bioreactors to permit both scale‐up/scale‐down of these cancer models and, importantly, methods to permit controlled changes in environment (pH, nutrients, and oxygen) are also described. The challenges of generating thin tumor slices, their utility, and potential advantages and disadvantages are discussed. These in vitro/ex vivo models represent a distinct move to capture the realities of tumor biology in situ, but significant characterization work still remains to be done in order to show that their biochemical circuitry accurately reflects that of a tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00075-9 · Cited by 4,180
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M., & Rosen, N. (2010) · Nature · doi:10.1038/nature08902 · Cited by 1,811
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Primary Bioassay of Human Tumor Stem Cells
Hamburger, A. W., & Salmon, S. E. (1977) · Science · doi:10.1126/science.560061 · Cited by 1,643
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B. J., Anderson, D. J., Alvarado, R., Ludlam, M. J. C., Stokoe, D., Gloor, S. L., Vigers, G., et al. (2010) · Nature · doi:10.1038/nature08833 · Cited by 1,622
Matrigel: A complex protein mixture required for optimal growth of cell culture
Hughes, C. S., Postovit, L. M., & Lajoie, G. A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900758 · Cited by 1,534
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M.-C., Validire, P., Trautmann, A., Mami-Chouaib, F., & Donnadieu, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45817 · Cited by 1,138
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · cited 1×
“Except for PDGF, all GFs provided rescue in some combinations [24].”
BackgroundPetersen, O. W., Rønnov-Jessen, L., Howlett, A. R., & Bissell, M. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9064 · Cited by 1,094
Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024
(1952) · Cancer Research · Cited by 987
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
Tung, Y.-C., Hsiao, A. Y., Allen, S. G., Torisawa, Y.-S., Ho, M., & Takayama, S. (2011) · The Analyst · doi:10.1039/c0an00609b · Cited by 969
Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Intratumor Heterogeneity: Evolution through Space and Time
Swanton, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2217 · Cited by 931
Development of PI3K inhibitors: lessons learned from early clinical trials
Rodon, J., Dienstmann, R., Serra, V., & Tabernero, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.10 · Cited by 766
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739
The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β
Park, J. S., Chu, J. S., Tsou, A. D., Diop, R., Tang, Z., Wang, A., & Li, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.019 · Cited by 735
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
Barcellos-Hoff, M. H., Aggeler, J., Ram, T. G., & Bissell, M. J. (1989) · Development · doi:10.1242/dev.105.2.223 · Cited by 711
Emerman, J. T., & Pitelka, D. R. (1977) · In Vitro · doi:10.1007/bf02616178 · Cited by 640
A murine tumor producing a matrix of basement membrane.
Orkin, R. W., Gehron, P., McGoodwin, E. B., Martin, G. R., Valentine, T., & Swarm, R. (1977) · The Journal of experimental medicine · doi:10.1084/jem.145.1.204 · Cited by 630
Independent regulation of tumor cell migration by matrix stiffness and confinement
Pathak, A., & Kumar, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118073109 · Cited by 568
A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone
Bersini, S., Jeon, J. S., Dubini, G., Arrigoni, C., Chung, S., Charest, J. L., Moretti, M., & Kamm, R. D. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.050 · Cited by 534
Inconsistency in large pharmacogenomic studies
Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C., Beck, A. H., Aerts, H. J. W. L., & Quackenbush, J. (2013) · Nature · doi:10.1038/nature12831 · Cited by 499
Phase III and submission failures: 2007–2010
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3375 · Cited by 480
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Alessandri, K., Sarangi, B. R., Gurchenkov, V. V., Sinha, B., Kießling, T. R., Fetler, L., Rico, F., Scheuring, S., Lamaze, C., Simon, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309482110 · Cited by 460
The tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
Optimized suspension culture: the rotating-wall vessel
Hammond, T. G., & Hammond, J. M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f12 · Cited by 437
Cancer Cell Lines for Drug Discovery and Development
Wilding, J. L., & Bodmer, W. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2971 · Cited by 432
Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-95 · Cited by 394
Human cancer cell lines: fact and fantasy
Masters, J. R. W. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043102 · Cited by 352
Härmä, V., Virtanen, J., Mäkelä, R., Happonen, A., Mpindi, J.-P., Knuuttila, M., Kohonen, P., Lötjönen, J., Kallioniemi, O., & Nees, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010431 · Cited by 344
Luca, A. C., Mersch, S., Deenen, R., Schmidt, S., Messner, I., Schäfer, K.-L., Baldus, S. E., Huckenbeck, W., Piekorz, R. P., Knoefel, W. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059689 · Cited by 341
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
Aoudjit, F., & Vuori, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204554 · Cited by 325
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.763.3.7 · Cited by 313
Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305
Process engineering of human pluripotent stem cells for clinical application
Serra, M., Brito, C., Correia, C., & Alves, P. M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.03.003 · Cited by 303
Self-citationBarrila, J., Radtke, A. L., Crabbé, A., Sarker, S. F., Herbst-Kralovetz, M. M., Ott, C. M., & Nickerson, C. A. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2423 · Cited by 302 · cited 1×
“Cells remain suspended in near free-fall, simulating microgravity conditions, which promote cell–cell interactions and minimize mechanical cell damage [108, 109], in the absence or presence of scaffolds [110, 111].”
BackgroundMyungjin Lee, J., Mhawech-Fauceglia, P., Lee, N., Cristina Parsanian, L., Gail Lin, Y., Andrew Gayther, S., & Lawrenson, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.41 · Cited by 301
A new instrument for the rapid preparation of tissue slices
Krumdieck, C. L., dos Santos, J., & Ho, K.-J. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90284-5 · Cited by 293
Clonogenic assay with established human tumour xenografts
Fiebig, H. H., Maier, A., & Burger, A. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.009 · Cited by 291
Emerman, J. T., Enami, J., Pitelka, D. R., & Nandi, S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4466 · Cited by 289
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology
Abaan, O. D., Polley, E. C., Davis, S. R., Zhu, Y. J., Bilke, S., Walker, R. L., Pineda, M., Gindin, Y., Jiang, Y., Reinhold, W. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3342 · Cited by 288
Acquired multicellular-mediated resistance to alkylating agents in cancer.
Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., & Kerbel, R. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3294 · Cited by 278
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907676107 · Cited by 267
Wenzel, C., Riefke, B., Gründemann, S., Krebs, A., Christian, S., Prinz, F., Osterland, M., Golfier, S., Räse, S., Ansari, N., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.017 · Cited by 254
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246
Self-citationMartin, K. J., Patrick, D. R., Bissell, M. J., & Fournier, M. V. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002994 · Cited by 224
Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor
Kunz‐Schughart, L. A. (1999) · Cell Biology International · doi:10.1006/cbir.1999.0384 · Cited by 215
Stem cell bioprocessing: fundamentals and principles
Placzek, M. R., Chung, I.-M., Macedo, H. M., Ismail, S., Mortera Blanco, T., Lim, M., Min Cha, J., Fauzi, I., Kang, Y., Yeo, D. C. L., et al. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0442 · Cited by 187
Kunz-Schughart, L. A., Schroeder, J. A., Wondrak, M., van Rey, F., Lehle, K., Hofstaedter, F., & Wheatley, D. N. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2005 · Cited by 184
Hongisto, V., Jernström, S., Fey, V., Mpindi, J.-P., Kleivi Sahlberg, K., Kallioniemi, O., & Perälä, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077232 · Cited by 181
Serra, M., Correia, C., Malpique, R., Brito, C., Jensen, J., Bjorquist, P., Carrondo, M. J. T., & Alves, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023212 · Cited by 179
Self-citationHypoxia and hypoxia inducible factors in tumor metabolism
Zeng, W., Liu, P., Pan, W., Singh, S. R., & Wei, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.032 · Cited by 170
Amann, A., Zwierzina, M., Gamerith, G., Bitsche, M., Huber, J. M., Vogel, G. F., Blumer, M., Koeck, S., Pechriggl, E. J., Kelm, J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092511 · Cited by 168
Frankel, A., Buckman, R. A., & Kerbel, R. S. (1997) · PubMed · Cited by 166
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
Huang, C., Park, C. C., Hilsenbeck, S. G., Ward, R., Rimawi, M. F., Wang, Y.-C., Shou, J., Bissell, M. J., Osborne, C. K., & Schiff, R. (2011) · Breast Cancer Research · doi:10.1186/bcr2936 · Cited by 165
Physiologically relevant organs on chips
Yum, K., Hong, S. G., Healy, K. E., & Lee, L. P. (2013) · Biotechnology Journal · doi:10.1002/biot.201300187 · Cited by 156
Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models
Costa, E. C., Gaspar, V. M., Coutinho, P., & Correia, I. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25210 · Cited by 156
Menendez, J. A., Vellon, L., Mehmi, I., Teng, P. K., Griggs, D. W., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208238 · Cited by 154
Versuche an Überlebendem Carcinomgewebe
Warburg, O. H., Negelein, E., & Posener, K. (1924) · Journal of Molecular Medicine · doi:10.1007/bf01736087 · Cited by 154
Bioreactors in tissue engineering
Plunkett, N. A., & O’Brien, F. J. (2011) · Technology and Health Care · doi:10.3233/thc-2011-0605 · Cited by 152
Using space-based investigations to inform cancer research on Earth
Becker, J. L., & Souza, G. R. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3507 · Cited by 148
Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space
Ma, X., Pietsch, J., Wehland, M., Schulz, H., Saar, K., Hübner, N., Bauer, J. W., Braun, M., Schwarzwälder, A., Segerer, J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-243287 · Cited by 141
Kunz‐Schughart, L. A., Heyder, P., Schroeder, J. A., & Knuechel, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5210 · Cited by 138
Howes, A. L., Chiang, G. G., Lang, E. S., Ho, C., Powis, G., Vuori, K., & Abraham, R. T. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0698 · Cited by 135
Tunggal, J. K., Cowan, D., Shaikh, H., & Tannock, I. F. (1999) · PubMed · Cited by 133
Fournier, M. V., Martin, K. J., Kenny, P. A., Xhaja, K., Bosch, I., Yaswen, P., & Bissell, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0515 · Cited by 133
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma
Koul, D., Shen, R., Kim, Y., Kondo, Y., Lu, Y., Bankson, J. A., Ronen, S. M., Kirkpatrick, D. L., Powis, G., & Yung, W. K. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop058 · Cited by 130
Microfluidics-assisted in vitro drug screening and carrier production
Tsui, J. H., Lee, W.-H., Pun, S. H., Kim, J., & Kim, D. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.004 · Cited by 126
Soman, P., Kelber, J. A., Lee, J. W., Wright, T. N., Vecchio, K. S., Klemke, R. L., & Chen, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.012 · Cited by 124
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
Merz, F., Gaunitz, F., Dehghani, F., Renner, C., Meixensberger, J., Gutenberg, A., Giese, A., Schopow, K., Hellwig, C. T., Schäfer, M., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not003 · Cited by 123
van der Kuip, H., Mürdter, T. E., Sonnenberg, M., McClellan, M., Gutzeit, S., Gerteis, A., Simon, W. E., Fritz, P., & Aulitzky, W. E. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-86 · Cited by 113
Jessup, J. M., Goodwin, T. J., & Spaulding, G. F. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240510308 · Cited by 113
Morphologic differentiation of colon carcinoma cell lines HT-29 and HT-29KM in rotating-wall vessels
Goodwin, T. J., Jessup, J. M., & Wolf, D. A. (1992) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631079 · Cited by 111
Cortazar, P., & Johnson, B. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1625 · Cited by 109
Green, S. K., Francia, G., Isidoro, C., & Kerbel, R. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.149.3.2 · Cited by 107
Gerlach, M. M., Merz, F., Wichmann, G., Kubick, C., Wittekind, C., Lordick, F., Dietz, A., & Bechmann, I. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.700 · Cited by 107
Patient-Specific 3D Microfluidic Tissue Model for Multiple Myeloma
Zhang, W., Lee, W. Y., Siegel, D. S. D., Tolias, P. P., & Zilberberg, J. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2013.0490 · Cited by 106
Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell Interactions
Gottfried, E., Kunz‐Schughart, L. A., Andreesen, R., & Kreutz, M. P. (2006) · Cell Cycle · doi:10.4161/cc.5.7.2624 · Cited by 105
Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing
Leite, S. B., Wilk–Zasadna, I., Zaldivar, J. M., Airola, E., Reis-Fernandes, M. A., Mennecozzi, M., Guguen‐Guillouzo, C., Chesné, C., gualbert, G. C., Alves, P. M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs232 · Cited by 104
Wang, R., Xu, J., Juliette, L., Castilleja, A., Love, J. E., Sung, S., Zhau, H. E., Goodwin, T. J., & Chung, L. W. K. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.005 · Cited by 103
Janus-Faced Tumor Microenvironment and Redox
Khramtsov, V. V., & Gillies, R. J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5864 · Cited by 100
(2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912 · Cited by 95
Cytotoxicity in human cell cultures as a primary screen for the detection of anti-tumor agents.
Eagle, H., & Foley, G. E. (1958) · PubMed · Cited by 95
Tostões, R. M., Leite, S. B., Miranda, J. P., Sousa, M. F. Q., Wang, D. I. C., Carrondo, M. J. T., & Alves, P. M. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22920 · Cited by 95
Rapid target gene validation in complex cancer mouse models using re‐derived embryonic stem cells
Huijbers, I. J., Ali, R. B., Pritchard, C. E. J., Cozijnsen, M., Kwon, M., Proost, N., Song, J., de Vries, H., Badhai, J., Sutherland, K., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303297 · Cited by 94
Becker, J. L., Prewett, T. L., Spaulding, G. F., & Goodwin, T. J. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240510307 · Cited by 91 · cited 1×
“Cells remain suspended in near free-fall, simulating microgravity conditions, which promote cell–cell interactions and minimize mechanical cell damage [108, 109], in the absence or presence of scaffolds [110, 111].”
BackgroundRhee, H. W., Zhau, H. E., Pathak, S., Multani, A. S., Pennanen, S., Visakorpi, T., & Chung, L. W. K. (2001) · In Vitro Cellular & Developmental Biology - Animal · Cited by 90
Stratmann, A. T., Fecher, D., Wangorsch, G., Göttlich, C., Walles, T., Walles, H., Dandekar, T., Dandekar, G., & Nietzer, S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.009 · Cited by 89
Ohmori, T., Yang, J.-L., Price, J. O., & Arteaga, C. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4261 · Cited by 88
Influence of Tumor pH on Therapeutic Response
Song, C. W., Griffin, R. J., & Park, H. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_2 · Cited by 87
Multiwell stiffness assay for the study of cell responsiveness to cytotoxic drugs
Zustiak, S. P., Nossal, R., & Sackett, D. L. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25097 · Cited by 76
Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement
af Hällström, T., Jäämaa, S., Mönkkönen, M., Peltonen, K., Andersson, L. C., Medema, R. H., Peehl, D. M., & Laiho, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609299104 · Cited by 73
Sonnenberg, M., van der Kuip, H., Haubeiß, S., Fritz, P., Schroth, W., Friedel, G., Simon, W. E., Mürdter, T. E., & Aulitzky, W. E. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-364 · Cited by 67
Scale-Up of Breast Cancer Stem Cell Aggregate Cultures to Suspension Bioreactors
Youn, B. S., Sen, A., Behie, L. A., Girgis-Gabardo, A., & Hassell, J. A. (2006) · Biotechnology Progress · doi:10.1021/bp050430z · Cited by 64
Thoma, C. R., Ströbel, S., Rösch, N., Calpe, B., Krek, W., & Kelm, J. M. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113499071 · Cited by 57
Hauptmann, S., Zwadlo-Klarwasser, G., Jansen, M., Klosterhalfen, B., & Kirkpatrick, C. J. (1993) · PubMed Central · Cited by 56
Seidl, P., Huettinger, R., Knuechel, R., & Kunz‐Schughart, L. A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10675 · Cited by 51
Integrating human stem cell expansion and neuronal differentiation in bioreactors
Serra, M., Brito, C., Costa, E., Sousa, M. F. Q., & Alves, P. M. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-82 · Cited by 51
Self-citationBrito, C., Simão, D. F., Costa, I., Malpique, R., Pereira, C. I., Fernandes, P., Serra, M., Schwarz, S. C., Schwarz, J., Kremer, E. J., et al. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.005 · Cited by 49
Self-citationEstes, J. M., Oliver, P. G., Straughn, J. M., Zhou, T., Wang, W., Grizzle, W. E., Alvarez, R. D., Stockard, C. R., LoBuglio, A. F., & Buchsbaum, D. J. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.12.033 · Cited by 49
Integrin Signaling as a Cancer Drug Target
Danen, E. H. J. (2013) · ISRN Cell Biology · doi:10.1155/2013/135164 · Cited by 49
Miniaturized pre-clinical cancer models as research and diagnostic tools
Håkanson, M., Cukierman, E., & Charnley, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.010 · Cited by 47
Test System for Trifunctional Antibodies in 3D MCTS Culture
Hirschhaeuser, F., Leidig, T., Rodday, B., Lindemann, C., & Mueller‐Klieser, W. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109341766 · Cited by 47
Meijer, A., Kruyt, F. A. E., van der Zee, A. G. J., Hollema, H., Le, P., ten Hoor, K. A., Groothuis, G. M. M., Quax, W. J., de Vries, E. G. E., & de Jong, S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.636 · Cited by 46
Biomimetic tumor microenvironment on a microfluidic platform
Ma, H., Xu, H. M., & Qin, J. (2013) · Biomicrofluidics · doi:10.1063/1.4774070 · Cited by 46
Cichon, M. A., Gainullin, V. G., Zhang, Y., & Radisky, D. C. (2011) · Integrative Biology · doi:10.1039/c1ib00090j · Cited by 42
Séveno, C., Loussouarn, D., Bréchet, S., Campone, M., Juin, P. P., & Barillé‐Nion, S. (2012) · Breast Cancer Research · doi:10.1186/bcr3214 · Cited by 42
Improved reproducibility in preparing precision-cut liver tissue slices
Zimmermann, M., Lampe, J. W., Lange, S., Smirnow, I., Königsrainer, A., Hann-von-Weyhern, C., Fend, F., Gregor, M., Bitzer, M., & Lauer, U. M. (2009) · Cytotechnology · doi:10.1007/s10616-009-9246-4 · Cited by 41
Pharma Firms Push for Sharing of Cancer Trial Data
Bhattacharjee, Y. (2012) · Science · doi:10.1126/science.338.6103.29 · Cited by 40
Lauer (2009) · International Journal of Oncology · doi:10.3892/ijo_00000253 · Cited by 39
Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action
Hirschhaeuser, F., Walenta, S., & Mueller‐Klieser, W. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0894-1 · Cited by 38
Thick-tissue bioreactor as a platform for long-term organotypic culture and drug delivery
Markov, D. A., Lu, J., Samson, P. C., Wikswo, J. P., & McCawley, L. J. (2012) · Lab on a Chip · doi:10.1039/c2lc40304h · Cited by 38
Semiautomatic Growth Analysis of Multicellular Tumor Spheroids
Rodday, B., Hirschhaeuser, F., Walenta, S., & Mueller‐Klieser, W. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111419501 · Cited by 38
Dong, M., Philippi, C., Loretz, B., Nafee, N. A., Schaefer, U. F., Friedel, G., Ammon-Treiber, S., Griese, E., Lehr, C., Klotz, U. E., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.009 · Cited by 36
Weissinger, D., Tagscherer, K. E., Macher-Göppinger, S., Haferkamp, A., Wagener, N., & Roth, W. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-120 · Cited by 34
Liu, Y., Lang, F., Xie, X., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2010.95 · Cited by 30
Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices
van Geer, M. A., Kuhlmann, K. F. D., Bakker, C., ten Kate, F. J. W., Elferink, R. P. J. O., & Bosma, P. J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1359 · Cited by 30
Kern, M. A., Haugg, A. M., Eiteneuer, E. M., Konze, E., Drebber, U., Dienes, H. P., Breuhahn, K., Schirmacher, P., & Kasper, H. U. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01268.x · Cited by 28
Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin
Schmid, J. O., Dong, M., Haubeiß, S., Friedel, G., Bode, S., Grabner, A., Ott, G., Mürdter, T. E., Oren, M., Aulitzky, W. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1201 · Cited by 27
Song, K., Liu, T., Li, X., Cui, Z.-F., Sun, X.-Y., & Ma, X. (2007) · PubMed · Cited by 27
Cell-based drug testing; this world is not flat
Grainger, D. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.001 · Cited by 26
Microfabricated polymeric vessel mimetics for 3-D cancer cell culture
Jaeger, A., Das, C. K., Morgan, N. Y., Pursley, R. H., McQueen, P. G., Hall, M. D., Pohida, T. J., & Gottesman, M. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.013 · Cited by 24
Breast cancer tissue slices as a model for evaluation of response to rapamycin
Grosso, S. H. G., Katayama, M. L. H., Roela, R. A., Nonogaki, S., Soares, F. A., Brentani, H., Lima, L. A., Folgueira, M. A. A. K., Waitzberg, Â. F. L., Pasini, F. S., et al. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1608-8 · Cited by 24
Tissue Culture of Intracranial Tumors with a Note on the Meningiomas.
Kredel, F. E. (1928) · PubMed Central · Cited by 24
Kerr, D. J., Wheldon, T. E., Kerr, A., Freshney, R. I., & Kaye, S. B. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.193 · Cited by 23
Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?
Das, T., & Chakraborty, S. K. (2013) · Biomicrofluidics · doi:10.1063/1.4789750 · Cited by 20
Pennington, K., Chu, Q. D., Curiel, D. T., et al. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.03.072 · Cited by 19
Merz, F., Müller, M., Taucher-Scholz, G., Rödel, F., Horst Stöcker, B., Schopow, K., Laprell, L., Dehghani, F., Durante, M., & Bechmann, I. (2010) · Radiation and Environmental Biophysics · doi:10.1007/s00411-010-0293-1 · Cited by 17
Growth and radiation response of cells grown in macroporous gelatin microcarriers (CultiSpher-G).
Rasey, J. S., Cornwell, M. M., Maurer, B. J., Boyles, D. J., Hofstrand, P. D., Chin, L. S., & Cerveny, C. G. (1996) · Europe PMC (PubMed Central) · Cited by 11
Drug Molecules and Biology: Network and Systems Aspects
Young, M. P., Zimmer, S., & Whitmore, A. V. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00032 · Cited by 9
Ya-jie Tang, A., Li, H., & Hamel, J. P. (2008) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-008-0267-8 · Cited by 4
Cited by
2D and 3D Cell Cultures - a Comparison of Different Types of Cancer Cell Cultures
Kapałczyńska, M., Kolenda, T., Przybyła, W., Zajączkowska, M., Teresiak, A., Filas, V., Ibbs, M., Bliźniak, R., Łuczewski, Ł., & Lamperska, K. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.63743 · Cited by 1,499
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
Intra-tumor heterogeneity from a cancer stem cell perspective
Prasetyanti, P. R., & Medema, J. P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0600-4 · Cited by 800
Current and emerging applications of 3D printing in medicine
Liaw, C.-Y., & Guvendiren, M. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7279 · Cited by 604
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428
Metadata
- Authors
- Hickman, J. A., Graeser, R., de Hoogt, R., Vidic, S., Brito, C., Gutekunst, M., van der Kuip, H., & IMI PREDECT consortium
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2014-09
- Volume
- 9
- Issue
- 9
- Pages
- 1115-1128
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2036959910
- Cited by
- 380
- References
- 148
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.